Liver and bile duct organoids and tumoroids - 21/08/24
Abstract |
Organoids refer to 3D cultures established to recapitulate histology, pathology, architecture, and genetic traits of various organs and tissues in the body, thereby replacing 2D cell cultures, xenograft, and animal models. Organoids form a 3D in vitro mimic of original tissues like the liver and are derived from embryonic or adult tissue stem cells. Liver and bile duct tumor organoids, also called, tumoroids capture genetic diversity, cellular, and pathophysiological properties of original tumors. Moreover, co-culture techniques along with genetic modulation of organoids allow for using tumoroids in liver and bile duct cancer research and drug screening/testing. Therefore, tumoroids are promising platforms for studying liver and bile duct cancer, which paves the way for the new era of personalized therapies. In the current review, we aimed to discuss liver and bile duct organoids with special emphasis on tumoroids and their applications, advantages, and shortcomings.
Le texte complet de cet article est disponible en PDF.Abbreviations : ARID1A, ARID2, BAP1, BMP, CTNNB1, DKK1, EGF, FGF, FGF10, FOXA1/2/3, GATA4, HGF, HNF4A, HNF1B, IL-6, HSP90, JAG1, KRAS, LGR5, MIR21, NF1, PTEN, SMAD4, ST14, TGF-β, TNF-α, Wnt
Keywords : Organoids, Liver Cancer, Bile Duct Tumors, Embryonic and Adult Tissues
Plan
Vol 178
Article 117104- septembre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?